Arachchige Sachin Eranga Pathigoda
CIK: 0002089972
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Pathigoda Arachchige Sachin Eranga
Pathigoda Arachchige Sachin Eranga (SEC CIK 0002089972) files insider reports with the SEC as Director of Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
Signal8 holds 1 ownership filing by Pathigoda Arachchige Sachin Eranga, a Form 3, filed on Oct 28, 2025. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Pathigoda Arachchige Sachin Eranga's filings is in GAITHERSBURG, MD.
Other insiders filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
- HRT FINANCIAL LP, 10% Owner
- Trasolini Ryan, Co-Chief Executive Officer
- Liang Yuying, Chief Financial Officer
- Liriano Angel, Director
- Chambers Adam V, Director
- Richards Steven M, Director